| ThRombosis ExclUsion STudy (NCT03477968) | Diagnostica Stago | 2018-06-25 |
| Venous thromboEmbolism Risk Profiles in Chinese hoSpitalized patiEnts (VERSE Study) (NCT05058521) | Beijing Tsinghua Chang Gung Hospital | 2018-06-01 |
| Study of Venous Thromboembolism Risk Profiles and Prophylaxis in Neurosurgical Inpatients (NCT04257305) | Huashan Hospital | 2018-06-01 |
| Allo - Cancer - Thrombosis (NCT03563924) | Assistance Publique - Hôpitaux de Paris | 2018-06-01 |
| The OPTICA Study - The Optimised Computed Tomography Pulmonary Angiography (CTPA) in Pregnancy, Quality and Safety Study (NCT04179487) | University College Dublin | 2018-05-29 |
| Development and Validation of Automated Indicators on the Appropriateness of Oral Anticoagulant Prescriptions (NCT02898090) | University Hospital, Bordeaux | 2018-04-28 |
| LIFE - Lung Cancer, Immunotherapy, Frailty, Effect (NCT03870464) | University of Southern Denmark | 2018-04-01 |
| Evaluation of Anti-Xa Levels in Surgery Patients Receiving Weight-based Heparin (NCT03516656) | University of Utah | 2018-03-23 |
| WAVe Study - Weight Adjusted Dalteparin for Patients Over 90 kg With Acute Cancer Associated Venous Thromboembolism (NCT03297359) | Ottawa Hospital Research Institute | 2018-03-21 |
| Comparision Between Activated Partial Thromboplastin Time Versus Anti-Xa Activity in Heparin Monitoring (NCT03426982) | Wuhan Asia Heart Hospital | 2018-03-01 |
| Apixaban for Primary Prevention of Venous Thromboembolism in Patients With Multiple Myeloma (NCT02958969) | Gregory Piazza | 2018-02-28 |
| WHITE Study: WHIch Decision After a First Venous ThromboEmbolism? (NCT04646993) | Arianna Anticoagulazione Foundation | 2018-02-01 |
| Venous Thromboembolism During COVID-19 Pandemic: Evaluation of the Association With the Vaccine and COVID-19 Infection (NCT06806800) | IRCCS Azienda Ospedaliero-Universitaria di Bologna | 2018-01-02 |
| Risk Factors of Venous Thromboembolism After Incisional Ventral Hernia Repair. (NCT05439187) | Pirogov Russian National Research Medical University | 2018-01-01 |
| Comparison of Bleeding Risk Between Rivaroxaban and Apixaban for the Treatment of Acute Venous Thromboembolism (NCT03266783) | Ottawa Hospital Research Institute | 2017-12-13 |
| Title: Randomized Trial of an EHR Embedded Risk Calculator vs. Standard VTE Prophylaxis for Medical Patients (NCT03243708) | The Cleveland Clinic | 2017-12-04 |
| Weight-Based Enoxaparin Dosing and Real-Time Dose Adjustment in Orthopaedic Trauma (NCT03339349) | University of Utah | 2017-11-15 |
| REduced Dose Versus Full-dose of Direct Oral Anticoagulant After uNprOvoked Venous thromboEmbolism. (NCT03285438) | University Hospital, Brest | 2017-11-02 |
| Study of Prophylactic Effect of Rivaroxaban on Venous Thromboembolism in AECOPD (NCT03277001) | Huashan Hospital | 2017-10-01 |
| Fixed Versus Weight-Based Enoxaparin Dosing in Thoracic Surgery Patients (NCT03251963) | University of Utah | 2017-09-15 |
| A Study of Dabigatran Etexilate as Primary Treatment of Malignancy Associated Venous Thromboembolism (NCT03240120) | The University of Hong Kong | 2017-09-01 |
| Monotherapy Anticoagulation To Expedite Home Treatment of Venous Thromboembolism (NCT03404635) | Indiana University | 2017-08-04 |
| Characterizing Recurrent Thromboembolism, Major Bleeding and All-Cause Death in Patients With Cancer-Associated Thromboembolism Treated With Rivaroxaban (NCT03214172) | Bayer | 2017-07-15 |
| Distribution of Risk Factors for Venous Thromboembolism in Blood Donors (NCT03282747) | Casa Sollievo della Sofferenza IRCCS | 2017-07-15 |
| Long Term Assessment of Post Thrombotic Syndrome : OPTIMEV Study ( SPOT ) (NCT03054727) | Association des Médecins Vasculaires Hospitaliers | 2017-07-11 |
| Incidence of Venous Thromboembolism in Patients Undergoing Major Esophageal Resection (NCT03115541) | McMaster University | 2017-07-10 |
| Minimization of Bleeding Related Adverse Drug Events in Plastic & Reconstructive Surgery (NCT03212365) | University of Utah | 2017-07-03 |
| PREvention of VENous ThromboEmbolism Following Radical Prostatectomy (NCT03006562) | Johns Hopkins University | 2017-07-01 |
| RIPT Feasibility Trial (NCT03070834) | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 2017-07-01 |
| Management of Platelet Transfusion Therapy in Patients With Blood Cancer or Treatment-Induced Thrombocytopenia (NCT03195010) | Fred Hutchinson Cancer Center | 2017-06-09 |
| Oral Anticoagulant Apixaban for Treatment of Venous Thromboembolism (NCT04041843) | New York Medical College | 2017-06-02 |
| Drug Interaction Study of Apixaban With Cyclosporine and Tacrolimus (NCT03083782) | Thomas Jefferson University | 2017-04-18 |
| Hemostatic Profiles of Endocrine Therapies for Breast Cancer (NCT03381963) | University Hospital, Geneva | 2017-04-01 |
| SToP: Venous Thromboembolism Screening in the Trauma Population (NCT02978950) | Intermountain Health Care, Inc. | 2017-03-20 |
| Identification of Novel Biomarkers to Aid in the Detection of Occult Cancer in Patients With Venous Thromboembolism (NCT03781531) | Danderyd Hospital | 2017-03-01 |
| Apixaban for Routine Management of Upper Extremity Deep Venous Thrombosis (NCT02945280) | Intermountain Health Care, Inc. | 2017-02-22 |
| Verification of XAPPORT: a Decision Support App for Physicians Used for Patients Anticoagulated With Rivaroxaban in Terms of Anticoagulation Management in Elective Surgery: Verification Process of Medical Decision Algorithm (NCT02900404) | Bayer | 2017-02-15 |
| Venous Thrombo-embolic Complication prévention in Pelvic Surgery (NCT03535428) | Fondation Hôpital Saint-Joseph | 2017-02-13 |
| STAT-STatin and Aspirin in Trauma (NCT02901067) | Denver Health and Hospital Authority | 2017-02-03 |
| Microsurgical Breast Reconstruction & VTE (NCT03031457) | Stanford University | 2017-01-30 |
| IgG Dependent Monocyte Activation in Proximal Venous Thromboembolism (NCT02713581) | Centre Hospitalier Universitaire de Nīmes | 2017-01-03 |
| Caprini Score in Venous Surgery: a Prospective Cohort Study (NCT03041805) | Pirogov Russian National Research Medical University | 2017-01-01 |
| An Observational Study on Incidence, Natural History and Treatment Patterns of Venous Thromboembolism in Taiwan (NCT03799016) | Bayer | 2016-12-15 |
| Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer (NCT02744092) | Alliance Foundation Trials, LLC. | 2016-12-13 |
| Evaluation of Anti-Xa Levels in Surgery Patients Receiving Fixed Dose Heparin (NCT02970032) | University of Utah | 2016-11-10 |
| Edoxaban Management in Diagnostic and Therapeutic Procedures (NCT02950168) | Daiichi Sankyo | 2016-11-01 |
| StAtins for Venous Event Reduction in Patients With Venous Thromboembolism Pilot Study (NCT02679664) | Ottawa Hospital Research Institute | 2016-11-01 |
| Anticoagulation Medical Home (NCT02870296) | University of Massachusetts, Worcester | 2016-10-21 |
| Multiple Algorithms System Of All Scores in Embolism (MOSE) (NCT02911012) | University Magna Graecia | 2016-10-01 |
| RAMBLE - Rivaroxaban vs. Apixaban for Heavy Menstrual Bleeding (NCT02829957) | Indiana University | 2016-09-01 |
| Effect of Clarithromycin on the Pharmacokinetics of Apixaban in Healthy Participants (NCT02912234) | Bristol-Myers Squibb | 2016-09-01 |
| Cancer Associated Thrombosis, a Pilot Treatment Study Using Rivaroxaban (NCT02746185) | Assistance Publique - Hôpitaux de Paris | 2016-09-01 |
| ELIQUIS (APIXABAN) Regulatory Post-Marketing Surveillance In Clinical Practice for Venous Thromboembolism (VTE) Treatment and Prevention Of Recurrent VTE (NCT02836457) | Bristol-Myers Squibb | 2016-07-01 |
| Tumor-educated Platelets in Venous Thromboembolism (NCT02739867) | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 2016-06-01 |
| Comparison of Bleeding Risk Between Rivaroxaban and Apixaban: The Pilot Study (NCT02559856) | Ottawa Hospital Research Institute | 2016-05-01 |
| : Pharmacokinetics of Enoxaparin After Coronary Artery Bypass Graft Surgery (NCT02474212) | Tampere University Hospital | 2016-05-01 |
| Thrombosis Outcomes in Pediatric Venous Thromboembolism (NCT03068923) | University of Texas Southwestern Medical Center | 2016-05-01 |
| Edoxaban Treatment in Routine Clinical Practice in Patients With Venous Thromboembolism in Europe (NCT02943993) | Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company | 2016-04-06 |
| Rivaroxaban in the Treatment of Venous Thromboembolism (VTE) in Cancer Patients (NCT02583191) | AIO-Studien-gGmbH | 2016-03-23 |
| Twice Daily Enoxaparin Prophylaxis in Reconstructive Surgery Patients (NCT02687204) | University of Utah | 2016-03-01 |
| Pilot Feasibility and Safety of Administering Weight Adjusted Fixed LMWH Dose (NCT02486666) | Hamilton Health Sciences Corporation | 2016-03-01 |
| Evaluation of Venous Thromboembolism Prevention in High-Risk Trauma Patients (NCT02412982) | University of Cincinnati | 2016-03-01 |
| Real-time Anti-Factor Xa Measurements in Surgical Patients to Examine Enoxaparin Metabolism and Optimize Enoxaparin Dose (NCT02704052) | University of Utah | 2016-03-01 |
| VTE Prophylaxis Guidelines in Hospitalized Elders (NCT03025100) | Duke University | 2016-02-01 |
| Aspirin and Enoxaparin for VTE in Trauma (NCT02396732) | University of Miami | 2016-02-01 |
| Thromboembolic and Hemorrhagic Complications of Anticoagulant Treatment in Patients With CAT (NCT06714734) | IRCCS Azienda Ospedaliero-Universitaria di Bologna | 2016-01-02 |
| Evaluation of the Short and Long Term Performance and Clinical Outcomes of the Crux Vena Cava Filter System (NCT02420626) | Volcano Corporation | 2016-01-01 |
| Thromboprophylaxis After Surgery for Gynecologic Malignancy in China (NCT02935530) | Huazhong University of Science and Technology | 2016-01-01 |
| Time of Treatment With LMWH in Cancer Patients With Thromboembolic Disease (NCT03134820) | Delos Clinical | 2015-12-15 |
| Treatment of Venous Thromboembolism in Real-Life Patients (NCT03087474) | Bristol-Myers Squibb | 2015-12-04 |
| Eliquis (VTE Treatment and Prevention of Recurrent VTE) rPMS (NCT02546817) | Bristol-Myers Squibb | 2015-11-30 |
| Apixaban for the Acute Treatment of Venous Thromboembolism in Children (NCT02464969) | Bristol-Myers Squibb | 2015-11-22 |
| Apixaban or Dalteparin in Reducing Blood Clots in Patients With Cancer Related Venous Thromboembolism (NCT02585713) | Academic and Community Cancer Research United | 2015-11-20 |
| Special Drug Use Investigation of Xarelto for Venous Thromboembolism (VTE) (NCT02558465) | Bayer | 2015-11-13 |
| RE-COVERY DVT/PE: Global Study on Treatment Secondary Prevention of Acute Venous Thromboembolism (NCT02596230) | Boehringer Ingelheim | 2015-11-05 |
| Enoxaparin 20mg Versus 30mg Subcutaneously Once Daily in Elderly Patients With Impaired Renal Function (NCT03158792) | Lebanese American University | 2015-10-24 |
| Tumescent Antibiotic Delivery for Prevention of Surgical Site Infection (NCT02503904) | Klein, Jeffrey A., M.D. | 2015-10-01 |
| The SYMPTOMS - SYstematic Elderly Medical Patients Thromboprophylaxis: Efficacy on Symptomatic OutcoMeS - Study (NCT02379806) | University Hospital, Brest | 2015-09-03 |
| Extended Low-Molecular Weight Heparin VTE Prophylaxis in Thoracic Surgery (NCT02334007) | McMaster University | 2015-09-01 |
| Using a Novel Algorithm to Improve the Retrieval Rate of Inferior Vena Cava Filters (iRetrieve Study) (NCT02160964) | Heart and Vascular Outcomes Research Institute | 2015-05-01 |
| Non Interventional Study of the Validation of the Ottawa Score in Cancer Patients With Venous Thromboembolism (VTE) (NCT03099031) | LEO Pharma | 2015-05-01 |
| Oral Apixaban (Eliquis) Versus Enoxaparin (Lovenox) for Thromboprophylaxis in Women With Suspected Pelvic Malignancy (NCT02366871) | University of Colorado, Denver | 2015-04-28 |
| Education Bundle to Decrease Patient Refusal of VTE Prophylaxis (NCT02402881) | Johns Hopkins University | 2015-04-01 |
| Patient Safety Learning Laboratory: Making Acute Care More Patient-Centered (NCT02969343) | Brigham and Women's Hospital | 2015-04-01 |
| Electronic Alert System for Improving Thromboprophylaxis in Hospitalized Medical Patients (NCT03124017) | Insel Gruppe AG, University Hospital Bern | 2015-03-01 |
| Enoxaparin Metabolism in Reconstructive Surgery Patients (NCT02411292) | University of Utah | 2015-03-01 |
| Direct Oral Anticoagulants and Venous Thromboembolism (NCT02833987) | Canadian Network for Observational Drug Effect Studies, CNODES | 2015-03-01 |
| Predicting the Risk of Venous Thromboembolism in Critically Ill Patients (NCT05498142) | University Medical Center Groningen | 2015-03-01 |
| Rate of Venous Thrombosis in Acutely Ill Patients Hospitalized in Internal Medicine Wards (NCT03157843) | University of Roma La Sapienza | 2015-02-01 |
| Prophylactic Use of Sodium Enoxaparin for Venous Thromboembolism in High-Risk Abdominal Surgery (NCT01308528) | Cristália Produtos Químicos Farmacêuticos Ltda. | 2015-02-01 |
| Haemorrhages and Thromboembolic Venous Disease of the Postpartum (NCT02443610) | University Hospital, Brest | 2015-01-06 |
| The Angel® Catheter Pivotal Clinical Trial (NCT02186223) | BiO2 Medical | 2015-01-01 |
| Statin Use in Patients With Acute VTE (NCT02331095) | Ohio State University | 2015-01-01 |
| Effectivity and Safety of Different Anticoagulants in Patients With Thromboembolic Antiphospholipid Syndrome (NCT05195372) | Cardioangiologisches Centrum Bethanien | 2015-01-01 |
| Risk Factors of Venous Thromboembolism After Colorectal Cancer Surgery (NCT06302179) | Pirogov Russian National Research Medical University | 2015-01-01 |
| Clinical Predictors for Venous Thromboembolism in Patients With a History of Thrombosis (PREDICTORS) (NCT02297373) | Ottawa Hospital Research Institute | 2014-11-19 |
| EINSTEIN Junior: Oral Rivaroxaban in Children With Venous Thrombosis (NCT02234843) | Bayer | 2014-11-13 |
| Phase 1 Pediatric Pharmacokinetics/Pharmacodynamics (PK/PD) Study (NCT02303431) | Daiichi Sankyo | 2014-11-05 |
| Venous Thromboembolic Complications in Ovarian Cancer (NCT02480790) | Ole Thorlacius-Ussing, MD, DMSc, Professor of Surgery | 2014-11-01 |
| Follow-up in Rivaroxaban Patients in Setting of Thromboembolism (NCT02248610) | King's College Hospital NHS Trust | 2014-11-01 |